Eris Lifesciences Ltd - Q4FY18 Beats Expectations, FY19E on Track
Eris Lifesciences Limited (ERIS IN) reported Q4FY18 results recently. Performance Highlights Eris reported Q4FY18 consolidated revenues at Rs 2.1...
210 Views
ERIS Lifesciences Limited – Acquisition Led Growth Story
Eris Lifesciences Limited (ERIS IN)Â is engaged in the marketing and manufacturing of branded generic drugs and derives all its revenues from the...
382 Views
Laurus Labs- Moving up the Value Addition Ladder
Laurus Labs (LAURUS IN) is a research and development driven pharmaceutical company. It is a manufacturer of APIs for ARV, Hepatitis C, oncology...
379 Views
HealthCare Global Enterprises (HCG)- A Niche Play in Burgeoning Indian Healthcare Sector
HealthCare Global Enterprises Limited (HCG IN) is a speciality healthcare provider with a focus on cancer and infertility treatment. It is the...
978 Views
Laurus Labs: Final Thoughts
The company has announced a price range of Rs 426 - 428 per share for its listing with bidding set to open on 6 December and closing on 8 December...
354 Views